KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $35.4 million.

  • Exact Sciences' Gains from Investment Securities rose 357186.27% to $35.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $57.3 million, marking a year-over-year increase of 181294.08%. This contributed to the annual value of $86.5 million for FY2025, which is 268448.89% up from last year.
  • Per Exact Sciences' latest filing, its Gains from Investment Securities stood at $35.4 million for Q4 2025, which was up 357186.27% from $8.7 million recorded in Q3 2025.
  • Exact Sciences' Gains from Investment Securities' 5-year high stood at $48.5 million during Q4 2021, with a 5-year trough of -$40.5 million in Q3 2021.
  • For the 5-year period, Exact Sciences' Gains from Investment Securities averaged around -$146263.2, with its median value being $1.0 million (2022).
  • Per our database at Business Quant, Exact Sciences' Gains from Investment Securities tumbled by 59830.34% in 2023 and then soared by 357186.27% in 2025.
  • Exact Sciences' Gains from Investment Securities (Quarter) stood at $48.5 million in 2021, then tumbled by 97.94% to $1.0 million in 2022, then tumbled by 598.3% to -$5.0 million in 2023, then surged by 79.57% to -$1.0 million in 2024, then skyrocketed by 3571.86% to $35.4 million in 2025.
  • Its Gains from Investment Securities was $35.4 million in Q4 2025, compared to $8.7 million in Q3 2025 and $4.9 million in Q2 2025.